<DOC>
	<DOCNO>NCT00998543</DOCNO>
	<brief_summary>The purpose study provide long-term follow-up immunogenicity safety data participant vaccinate second-generation smallpox vaccine Study VVL04 ( NCT 00258947 ) . Primary Objectives : Immunogenicity : To yearly describe vaccinia antibody persistence 5 year post-vaccination . Safety : To follow-up long-term safety 5 year post-vaccination .</brief_summary>
	<brief_title>A Long-Term Study Healthy Adults Vaccinated With One Dose Smallpox Vaccine ( LISTER Strain )</brief_title>
	<detailed_description>None participant study receive vaccination part study . All participant provide blood sample immunogenicity test 1 , 2 , 3 , 4 , 5 year anniversary vaccination . Safety assess 5 year vaccination , include follow-up reaction occur Study VVL04 ( NCT 00258947 ) .</detailed_description>
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Subject vaccinate complete Phase II VVL04 trial . Informed consent form sign . Subject able comply trial procedure . Subject entitle national social security . Exclusion Criteria : Subject deprive freedom administrative court order , emergency setting , hospitalize without his/her consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Smallpox Vaccinia Virus Smallpox Vaccine Variola Virus</keyword>
</DOC>